CAS NO: | 236395-14-5 |
生物活性 | Eslicarbazepine acetate (BIA 2-093), an antiepileptic drug, is a dual a dual Inhibitor ofβ-Secretaseand voltage-gatedsodium channel. | ||||||||||||||||
体内研究 (In Vivo) | Eslicarbazepine acetate is an antiepileptic drug. It is a prodrug which is activated to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine. Eslicarbazepine acetate is a prodrug for (S)-(+)-licarbazepine, the major active metabolite of oxcarbazepine. Its mechanism of action is therefore identical to that of oxcarbazepine. Eslicarbazepine acetate may not produce as high peak levels of (S)-(+)-licarbazepine immediately after dosing as does oxcarbazepine which could theoretically improve tolerability[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 296.32 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H16N2O3 | ||||||||||||||||
CAS 号 | 236395-14-5 | ||||||||||||||||
中文名称 | 醋酸艾司利卡西平;艾司利卡西平醋酸盐 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(337.47 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |